Micronesian Discussion Guide: Talking to Your Doctor about Hepatitis B
This discussion guide addresses what questions one should ask their doctor after a hepatitis B diagnosis.
Viral Hepatitis
Back to Results
How is Hepatitis B Passed from Person to Person? Myths and Misconceptions
This infographic discusses how hepatitis is spread from person to person. It is intended for the Micronesian population.
Physician Directory
This webpage is an online group for qualified liver specialists who are knowledgeable about chronic hepatitis B to be listed in the Hepatitis B Foundation's Physician Directory.
Pharmaceutical Company Patient Assistance and Cost-sharing Assistance Programs: Hepatitis
This guideline discusses pharmaceutical company patience assistance and cost-sharing assistance programs for viral hepatitis.
Thinking About Starting a Supportive Housing Program? Recommendations and Considerations for the Planning Process
This guideline, Informed by conversations with current housing and harm reduction service providers, Thinking About Starting a Supportive Housing Program? Recommendations and Considerations for the Planning Process may be used to help inform programmatic development for supportive housing. It is intended for governmental and community-based organizations that are interested in developing housing programs within their organization or collaborating with other partners in their communities.
HCV Elimination Among People Living with and at Risk of HIV: Challenges and Opportunities
This webinar highlights best practices and challenges for HCV elimination with a specific focus on high-burden populations.
HepVu 2022 Surveillance Status Report Briefing
The webinar walks through the HepVu 2022 Viral Hepatitis Surveillance Status Report.
2022 Viral Hepatitis Surveillance Status Report Toolkit
This toolkit includes sample social media messages and infographics to amplify and highlight the key findings from the 2022 Viral Hepatitis Surveillance Status Report.
2022 Viral Hepatitis Surveillance Status Report
This infographic is an assessment of the status of viral hepatitis surveillance practices across U.S. jurisdictions in 2022.
Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)
The purpose of this Funding Opportunity Announcement (FOA) is to encourage pilot and/or feasibility research in the following areas: 1) the development and pilot testing of new or adapted interventions to prevent or delay the initiation of substance use and/or the progression from use to misuse or disorder and 2) pre-trial feasibility and acceptability testing of services and service system research relevant to the prevention of substance use.